Package 31722-778-01

{"route": ["ORAL"], "spl_id": "49d4285f-03ac-75ae-e063-6294a90a0da0", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0331722777018", "0331722778015"], "unii": ["X4HES1O11F"], "rxcui": ["197311", "197313"], "spl_set_id": ["0910335b-6796-459f-b97e-d7ef5439a060"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (31722-778-01)", "package_ndc": "31722-778-01", "marketing_start_date": "20131129"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (31722-778-05)", "package_ndc": "31722-778-05", "marketing_start_date": "20131129"}], "brand_name": "Acyclovir", "product_id": "31722-778_49d4285f-03ac-75ae-e063-6294a90a0da0", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "31722-778", "generic_name": "Acyclovir", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "800 mg/1"}], "application_number": "ANDA203834", "marketing_category": "ANDA", "marketing_start_date": "20131129", "listing_expiration_date": "20271231"}